Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Dehydroepiandrosterone (DHEA) exerts beneficial effects on blood glucose levels and insulin sensitivity in obese rodents and humans, resembling the effects of peroxisome proliferator-activated receptor-γ (PPARγ) ligands and opposing those of glucocorticoids; however, the underlying mechanisms remain unclear. Glucocorticoids are reactivated locally by 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), which is currently considered as a promising target for the treatment of obesity and diabetes. Using differentiated 3T3-L1 adipocytes, we show that DHEA causes downregulation of 11β-HSD1 and dose-dependent reduction of its oxoreductase activity. The effects of DHEA were comparable with those of the PPARγ agonist rosiglitazone but not additive. Furthermore, DHEA reduced the expression of hexose-6-phosphate dehydrogenase, which stimulates the oxoreductase activity of 11β-HSD1. These findings were confirmed in white adipose tissue and in liver from DHEA-treated C57BL/6J mice. Analysis of the transcription factors involved in the DHEA-dependent regulation of 11β-HSD1 expression revealed a switch in CCAAT/enhancer-binding protein (C/EBP) expression. C/EBPα, a potent activator of 11β-HSD1 gene transcription, was downregulated in 3T3-L1 adipocytes and in liver and adipose tissue of DHEA-treated mice, whereas C/EBPβ and C/EBPδ, attenuating the effect of C/EBPα, were unchanged or elevated. Our results further suggest a protective effect of DHEA on adipose tissue by upregulating PPARα and downregulating leptin, thereby contributing to the reduced expression of 11β-HSD1. In summary, we provide evidence that some of the anti-diabetic effects of DHEA may be caused through inhibition of the local amplification of glucocorticoids by 11β-HSD1 in adipose tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Kopelman, P. G. (2000) · Nature · doi:10.1038/35007508 · Cited by 4,795 · cited 1×
“In visceral adipose tissue, excessive glucocorticoids further enhance lipolysis, leading to high levels of free fatty acids, ultimately resulting in the development of insulin resistance and type 2 diabetes (21).”
BackgroundControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821 · cited 1×
“In contrast, PGC-1 is elevated in the liver in fasting and in diabetes and increases the hepatic gluconeogenesis (60).”
BackgroundA transgenic model of visceral obesity and the metabolic syndrome
Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · cited 3×
“The importance of the local activation of glucocorticoids in adipose tissue has been demonstrated recently in transgenic mice overexpressing 11 -HSD1 under the adipose-specific AP2 promoter/enhancer (30).”
BackgroundLabrie, F. (1991) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(91)90116-a · Cited by 685
Morton, N. M., Paterson, J. M., Masuzaki, H., Holmes, M. C., Staels, B., Fievet, C., Walker, B. R., Flier, J. S., Mullins, J. J., & Seckl, J. R. (2004) · Diabetes · doi:10.2337/diabetes.53.4.931 · Cited by 512 · cited 2×
“Thus, supplementation therapy may help to treat the progressive decline of circulating DHEA levels with aging and may prevent elevated intra-adipose cortisol levels (or corticosterone in rodents), which antagonize the effects of insulin and induce hypertrophy and visceral fat accumulation (30, 35).”
BackgroundMasuzaki, H., Yamamoto, H., Kenyon, C. J., Elmquist, J. K., Morton, N. M., Paterson, J. M., Shinyama, H., Sharp, M. G. F., Fleming, S., Mullins, J. J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17845 · Cited by 434 · cited 1×
“They developed the full metabolic syndrome characterized by visceral obesity, insulin-resistant diabetes, hyperlipidemia, and high arterial blood pressure due to an increased sensitivity to dietary salt and increased plasma levels of angiotensinogen, angiotensin II, and aldosterone (30, 31).”
BackgroundField, A. E., Colditz, G. A., Willett, W. C., Longcope, C., & McKinlay, J. B. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962322 · Cited by 421 · cited 1×
“Several studies demonstrated a significant negative association between DHEA and the accumulation of abdominal fat, suggesting that low circulating DHEA is associated with a more central distribution of adipose tissue (8, 9, 53).”
BackgroundVillareal, D. T., & Holloszy, J. O. (2004) · JAMA · doi:10.1001/jama.292.18.2243 · Cited by 241
Lindsay, R. S., Wake, D. J., Nair, S., Bunt, J., Livingstone, D. E. W., Permana, P. A., Tataranni, P. A., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-030017 · Cited by 225 · cited 1×
“expression of 11β-HSD1 found in subcutaneous adipose tissue from individuals with aquired obesity and by its positive correlation with the accumulation of subcutaneous and intra-abdominal fat, body mass index, percentage of body fat, waist circumference, as well as fasting glucose, insulin levels and insulin resistanc…”
Background
Cited by
11β-hydroxysteroid dehydrogenases: Intracellular gate-keepers of tissue glucocorticoid action
Chapman, K., Holmes, M., & Seckl, J. (2013) · Physiological Reviews · doi:10.1152/physrev.00020.2012 · Cited by 887
Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.11.002 · Cited by 769
Leptin in Pregnancy: An Update1
Henson, M. C., & Castracane, V. D. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.105.045120 · Cited by 271
Dehydroepiandrosterone as a regulator of immune cell function
Hazeldine, J., Arlt, W., & Lord, J. M. (2010) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.12.016 · Cited by 173
DHEA enhances effects of weight training on muscle mass and strength in elderly women and men
Villareal, D. T., & Holloszy, J. O. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00100.2006 · Cited by 116
“DHEA replacement causes small increases in insulin-like growth factor I (IGF-I) and testosterone levels (13, 26, 39), and DHEA has been reported to have an anti-glucocorticoid effect (1, 24, 41).”
Metadata
- Authors
- Apostolova, G., Schweizer, R. A. S., Balazs, Z., Kostadinova, R. M., & Odermatt, A.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2005-05
- Volume
- 288
- Issue
- 5
- Pages
- E957-E964
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2016909719
- Cited by
- 89
- References
- 14
- FWCI
- 1.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. https://app.cochat.ai/papers/10.1152/ajpendo.00442.2004
- The paper
- Apostolova, G., Schweizer, R. A. S., Balazs, Z., Kostadinova, R. M., & Odermatt, A. (2005). Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. American Journal of Physiology-Endocrinology and Metabolism. https://doi.org/10.1152/ajpendo.00442.2004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.